ARCHIVES

Raloxifene Protects Women At High or Low Risk of Disease

This article is from The Cancer Letter archive.

Vol. 29 No. 9 | September 29, 2006

Download PDF Visit The Full Archive

Related Articles

ACCC 10th Anniversary Meeting Zeroes in On Impact Of DRGs

February 24, 1984

DSMB Recommends Discontinuing Phase III Perifosine Combination Trial

March 29, 2013

NTP Board Oks Seven Compounds For Tests

April 22, 1983

House Committee Probes NCI $5.2 Billion Sole-Source Contract With SAIC-Frederick.

November 14, 2008

Copyright Violation Of Cancer Letter – Results In Payment

July 19, 1991

BMS Control Of Billion-Dollar Taxol Market Facing Court Challeges By Competitors

May 29, 1998